About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Infectious Diseases
›
Top Articles
Journal of Infectious Diseases
Biology
,
Microbiology
,
Immunology
7
(top 2%)
Impact Factor
7.6
(top 2%)
extended IF
307
(top 1%)
H-Index
10.3K
authors
31.2K
papers
1.4M
citations
13.3K
citing journals
206.4K
citing authors
Most Cited Articles of Journal of Infectious Diseases
Title
Year
Citations
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface
1981
1.2K
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
2000
1.2K
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
1985
1.2K
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE
2008
1.1K
Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study
1989
1.1K
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness
2008
1.1K
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
2005
1K
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
2010
984
Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent
1987
962
A quantitative immunochemical measure of the primary interaction between I BSA and antibody
1958
959
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration
1987
958
Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease
1995
950
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise
2000
924
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System
1993
917
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings
2010
882
Experimental Campylobacter jejuni infection in humans
1988
869
Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
1999
847
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu
1972
812
Plasma levels of soluble CD14 independently predict mortality in HIV infection
2011
801
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea
2008
764
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
2005
727
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study
1995
707
Isolation of the etiologic agent of Korean Hemorrhagic fever
1978
703
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice
2004
693
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
2003
690
previous
1992
1993
1994
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.